The DOI matches its Crossref record; 45 of the 46 references it cites were found in a registry or an index.
Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2
Open accessAbstract
An increasing number of studies indicate that adrenergic signalling plays a fundamental role in chronic stress-induced tumour progression and metastasis. However, its function in gastric cancer (GC) and its potential mechanisms remain unknown. The expression levels of β-adrenergic receptor (ADRB) in GC cell lines were examined by using real-time polymerase chain reaction (RT-PCR) and western blotting. The effects of β2 adrenergic receptor (ADRB2) activation and blockade were investigated in vitro in GC cells by using proliferation, migration, invasion, cell cycle and apoptosis assays. Chronic restraint stress (CRS) increased the plasma levels of catecholamines and cortisol and also induced progression and metastasis of GC in vivo. Furthermore, immunohistochemical staining and a TUNEL assay were employed to observe the regulation of cell viability in vivo. The expression levels of ADRB2 in 100 human GC samples were measured by RT-PCR and immunohistochemistry. The stress hormones epinephrine and norepinephrine significantly accelerated GC cell proliferation, invasion and viability in culture, as well as tumour growth in vivo. These effects were reversed by the ADRB antagonists propranolol and ICI118,551 (an ADRB2-specific antagonist). Moreover, the selective ADRB1 antagonist atenolol had almost no effect on tumour cell proliferation and invasion in vitro and in vivo. ADRB2 antagonists suppressed proliferation, invasion and metastasis by inhibiting the ERK1/2-JNK-MAPK pathway and transcription factors, such as NF-κB, AP-1, CREB and STAT3. Analysis of xenograft models using GC cells revealed that ADRB2 antagonists significantly inhibited tumour growth and metastasis, and chronic stress antagonized these inhibitory effects. In addition, chronic stress increased the expression of VEGF, MMP-2, MMP-7 and MMP-9 in transplanted tumour tissue, and catecholamine hormones enhanced the expression of metastasis-related proteins. The expression of ADRB2 was upregulated in tumour tissues and positively correlated with tumour size, histological grade, lymph node metastasis and clinical stage in human GC samples. Stress hormone-induced activation of the ADRB2 signalling pathway plays a crucial role in GC progression and metastasis. These findings indicate that ADRB2 signalling regulates GC progression and suggest β2 blockade as a novel strategy to complement existing therapies for GC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, β-adrenergic signaling has been implicated in promoting EMT and increasing the metastatic potential in cancer cells via the VEGF/MMP and STAT3/ERK/MAPK pathways.321”
From Drug repurposing for cancer therapy (2024) · cites this paper as [321]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“ADRB2 antagonists such as propranolol and ICI118,551 suppressed gastric cancer progression by inhibiting the ERK1/2-JNK-MAPK pathway and transcription factors, such as NF-κB, AP-1, and STAT3 (14).”
From Chronic Stress Promotes Cancer Development (2020) · cites this paper as [14]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell-cycle checkpoints and cancer
Kastan, M. B., & Bartek, J. (2004) · Nature · doi:10.1038/nature03097 · Cited by 2,836
Stress, depression, the immune system, and cancer
Reiche, E. M. V., Nunes, S. O. V., & Morimoto, H. K. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01597-9 · Cited by 1,364
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma
Thaker, P. H., Han, L. Y., Kamat, A. A., Arevalo, J. M., Takahashi, R., Lu, C., Jennings, N. B., Armaiz-Pena, G., Bankson, J. A., Ravoori, M., et al. (2006) · Nature Medicine · doi:10.1038/nm1447 · Cited by 1,320
Autonomic nerve development contributes to prostate cancer progression
Magnon, C., Hall, S. J., Lin, J., Xue, X., Gerber, L., Freedland, S. J., & Frenette, P. S. (2013) · Science · doi:10.1126/science.1236361 · Cited by 1,287
The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, M. H., Lutgendorf, S. K., Cole, S. W., Dhabhar, F. S., Sephton, S. E., McDonald, P. G., Stefanek, M., & Sood, A. K. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1820 · Cited by 981
The sympathetic nervous system induces a metastatic switch in primary breast cancer
Sloan, E. K., Priceman, S. J., Cox, B. F., Yu, S., Pimentel, M. A., Tangkanangnukul, V., Arevalo, J. M. G., Morizono, K., Karanikolas, B. D. W., Wu, L., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0522 · Cited by 930
Molecular Pathways: Beta-Adrenergic Signaling in Cancer
Cole, S. W., & Sood, A. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0641 · Cited by 713
Denervation suppresses gastric tumorigenesis
Zhao, C., Hayakawa, Y., Kodama, Y., Muthupalani, S., Westphalen, C. B., Andersen, G. T., Flatberg, A., Johannessen, H., Friedman, R. A., Renz, B. W., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009569 · Cited by 687
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer
Renz, B. W., Takahashi, R., Tanaka, T., Macchini, M., Hayakawa, Y., Dantes, Z., Maurer, H. C., Chen, X., Jiang, Z., Westphalen, C. B., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2017.11.007 · Cited by 543
Zhang, M., He, Y., Sun, X., Li, Q. Y., Wang, W., Zhao, A., & Di, W. J. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-19 · Cited by 530
Research works printed but not linked: 1
- Guo, Y. et al. Role of the autonomic nervous system in the tumor micro-environment and its therapeutic potential. Curr. Pharm. Des. 23, 1687–1692 (2017). · DOI
Cited by
Sorted by citations
Items 101–200 of 260
The Apoptotic Resistance of BRCA1-Deficient Ovarian Cancer Cells is Mediated by cAMP
Yue, W., Ma, J., Xiao, Y., Wang, P., Gu, X., Xie, B., & Li, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.889656 · Cited by 13
Bearing allostatic load: insights into a more equitable future within cardio-oncology
Barrett, M., Wilcox, N. S., Huang, A., Levy, R., Demissei, B. G., Narayan, V., & Ky, B. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.09.006 · Cited by 12
Impact of chronic stress on intestinal mucosal immunity in colorectal cancer progression
Yang, S., Li, Y., Zhang, Y., & Wang, Y. (2024) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2024.10.007 · Cited by 12
Self-citationIdentify potential miRNA-mRNA regulatory networks contributing to high-risk neuroblastoma
Shao, F., Liu, Q., & Wang, S. (2021) · Investigational New Drugs · doi:10.1007/s10637-021-01064-y · Cited by 12
A local sympathetic-immune axis inhibits melanoma growth in mice by dictating adrenergic control
Liu, T., Kutsovsky, D. Y., Earlie, E. M., Ji, L., Iskols, M., Ramsamooj, S., Dawkins, X. I., Zerhouni, M., Birbrair, A., Piskounova, E., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.016 · Cited by 13
Tiwari, R. K., Rawat, S. G., & Kumar, A., V (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110825 · Cited by 11
Xu, F., Cao, J., Cao, J., Xiao, Z., Yang, Z., Yang, Z., Duan, J., & Xu, F. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1485885 · Cited by 11
Li, N., Tong, H., Hou, W., Liu, Q., Xiang, F., Zhu, J., Xu, S., He, Z., & Wang, B. (2025) · Cancer Letters · doi:10.1016/j.canlet.2025.217589 · Cited by 11
Self-citationGao, J., & Liu, S. (2021) · Chinese Medical Journal · doi:10.1097/cm9.0000000000001348 · Cited by 11
Yu, B., Liang, J., Li, X., Liu, L., Yao, J., Chen, X., & Chen, R. (2022) · Molecules · doi:10.3390/molecules27165337 · Cited by 11
Chronic stress promotes gastric cancer progression via the adrenoceptor beta 2/PlexinA1 pathway
Lu, Y., Cheng, D., Pang, J., Peng, Y., Jin, S., Zhang, X., Li, Y., & Zuo, Y. (2024) · Cell Stress and Chaperones · doi:10.1016/j.cstres.2024.02.001 · Cited by 10
Self-citationUnlocking the potential: Receptor-mediated targeted drug delivery in cancer therapy
Palanisamy, B., & Mandal, A. K. A. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.155955 · Cited by 10
Expression of M3 muscarinic acetylcholine receptors in gastric cancer
Mehedințeanu, A. M., Mirea, C. S., Stovicek, P. O., Schenker, M., Stancu, M. I., Ciurea, A.-M., Streba, L., Istrate-Ofiţeru, A. M., Sas, T.-N., & Vere, C. C. (2022) · Romanian Journal of Morphology and Embryology · doi:10.47162/rjme.62.4.12 · Cited by 10
zong, C., Yang, M., Guo, X., & Ji, W. (2022) · Oncology Letters · doi:10.3892/ol.2022.13420 · Cited by 12
Wang, K., Mao, W., Shi, H., Wang, G., Yin, L., Xie, J., Ian, L. H., Zhang, H., & Peng, B. (2020) · Translational Andrology and Urology · doi:10.21037/tau-20-605 · Cited by 9
Zenga, J., Awan, M. J., Frei, A. C., Petrie, E., Sharma, G. P., Shreenivas, A. V., Shukla, M., & Himburg, H. A. (2022) · Head & Neck · doi:10.1002/hed.27028 · Cited by 10
Oncogenic LINC00857 recruits TFAP2C to elevate FAT1 expression in gastric cancer
Zhang, W., Ji, K., Min, C., Zhang, C., Yang, L., Zhang, Q., Tian, Z., Zhang, M., Wang, X., & Li, X. (2022) · Cancer Science · doi:10.1111/cas.15394 · Cited by 10
Chen, G., Hu, B., Chen, H., Zhu, J., Nie, J., Hua, L., Chen, L., Fang, Y., Hang, C., & Lu, Y. (2022) · Journal of Molecular Histology · doi:10.1007/s10735-022-10076-8 · Cited by 9
Komine, C., Sohda, M., Yokobori, T., Shioi, I., Ozawa, N., Shibasaki, Y., Nakazawa, N., Osone, K., Shiraishi, T., Okada, T., et al. (2024) · Annals of Surgical Oncology · doi:10.1245/s10434-024-16195-8 · Cited by 9
Zhao, H., Yin, Y., Lin, T., Wang, W., & Gong, L. (2023) · Experimental Eye Research · doi:10.1016/j.exer.2023.109486 · Cited by 9
The Neuroimmune Axis and Its Therapeutic Potential for Primary Liver Cancer
Mandal, S. K., Yadav, P., & Sheth, R. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116237 · Cited by 10
Tumor Innervation: From Bystander to Emerging Therapeutic Target for Cancer
Ji, Z. Z., Chan, M. K., Tang, P. C., Ng, C. S. H., Li, C., Zhang, D., Nikolic‐Paterson, D. J., To, K., Jiang, X., & Tang, P. M.-K. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189257 · Cited by 11
Puri, P., Grimmett, G., Faraj, R., Gibson, L., Gilbreath, E., & Yoder, B. K. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.06.001 · Cited by 8
Ke, M., Zeng, L., Yang, C., & Yang, S. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s430408 · Cited by 8
Wu, S., Guan, W., Zhao, H., Li, G., Zhou, Y., Shi, B., & Zhang, X. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1277383 · Cited by 8
Self-citationNeurobiology of Cancer: Introduction of New Drugs in the Treatment and Prevention of Cancer
Mravec, B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22116115 · Cited by 8
The Nervous System as a Regulator of Cancer Hallmarks: Insights into Therapeutic Implications
Torres-Juárez, K. V., QUEIROGA, F. L., & Romero-Romero, L. P. (2022) · Cancers · doi:10.3390/cancers14184372 · Cited by 9
Sáinz, J., García‐Verdejo, F. J., Martínez‐Bueno, M., Kumar, A., Sánchez‐Maldonado, J. M., Díez-Villanueva, A., Vodičková, L., Vymetalkova, V. P., Martín, V., Filho, M. I. D. S., et al. (2021) · Cancers · doi:10.3390/cancers13061258 · Cited by 8
Huang, R., Fujimura, A., Nakata, E., Takihira, S., Inoue, H., Yoshikawa, S., Hiyama, T. Y., Ozaki, T., & Kamiya, A. (2021) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2021.03.172 · Cited by 8
Feng, M., Wang, H., Zhu, Z., Yao, B., Li, Y., Xue, J., Cao, S., Shao, X., Xu, Y., Sohn, K. C., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.677939 · Cited by 8
Ge, M., Zhang, W., Zhang, W., Zhang, Z., Zeng, X., Deng, L., Wen, M., Lu, X., Shen, X., Li, Z., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.001 · Cited by 8
Lin, X., He, J., Liu, F., Li, L., Sun, L., Niu, L., Xi, H., Zhan, Y., Liu, X., & Hu, P. (2023) · Oncology Letters · doi:10.3892/ol.2023.14106 · Cited by 7
Attia, Y. M., Hakeem, A. N., Samir, R., Mohammed, A., Elsayed, A., Khallaf, A., Essam, E., Amin, H., Abdullah, S., Hikmat, S., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1362675 · Cited by 7
Crnovrsanin, N., Zumsande, S., Rompen, I. F., Schiefer, S., Zimmer, S., Hu, W., Arnscheidt, J., Brinkmann, F., Longerich, T., Haag, G. M., et al. (2025) · Annals of Surgical Oncology · doi:10.1245/s10434-025-17233-9 · Cited by 8
Potential role of LPAR5 gene in prognosis and immunity of thyroid papillary carcinoma and pan-cancer
Zhang, B., Zhang, L., Qi, P., Pang, R., Wang, Z., Liu, X., Shi, Q., & Zhang, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-32733-y · Cited by 7
Self-citationα5-nAChR/NETO2 contributed to chronic stress-promoted lung adenocarcinoma progression
Wang, J., Cai, J., Wang, Z., Yang, S., Wang, J., Jia, Y., Sun, H., & Ma, X. (2025) · Cancer Cell International · doi:10.1186/s12935-025-03701-5 · Cited by 6
Role of adrenergic receptors and their blocking in cancer research
Gazova, S., Klena, L., Galvankova, K., Babula, P., & Križanová, O. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118637 · Cited by 8
Li, G., Li, F., Tang, Y., Guo, S., Yao, Y., Yuan, F., Zhang, B., Jiang, Y. Y., Wang, J., Wu, D., et al. (2025) · MedComm · doi:10.1002/mco2.70556 · Cited by 6
Luo, S., Long, H., Lou, F., Liu, Y., Wang, H., Pu, J., Ji, P., & Jin, X. (2024) · BMC Oral Health · doi:10.1186/s12903-023-03787-1 · Cited by 6
Modeling human gastric cancers in immunocompetent mice
Zhang, W., Wang, S., Zhang, H., Meng, Y., Jiao, S., An, L., & Zhou, Z. (2024) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2024.0124 · Cited by 8
Jiang, M., Wang, S., Ji, J., Baral, S., Sun, Q., Wang, Y., Liu, B., Ren, J., Wang, W., & Wang, D. (2024) · APOPTOSIS · doi:10.1007/s10495-024-02049-x · Cited by 6
Neuroimmune axis in gastrointestinal cancers: From mechanisms to therapeutic breakthrough
Zhang, Y., Chen, J., Zhou, Y., Jiang, Y., Hu, J., Liu, X., & Zhou, J. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116059 · Cited by 7
Self-citationNair, I. B., Manish, K., & Peter, M. C. S. (2023) · Proceedings of the Zoological Society · doi:10.1007/s12595-023-00508-y · Cited by 6
Zhou, Q., Katano, M., Zhang, J.-H., Liu, X., Wang, K., Iinuma, M., Kubo, K., & Azuma, K. (2021) · Brain Sciences · doi:10.3390/brainsci11040479 · Cited by 6
Wang, X., Deng, Y., Zheng, P., Sun, X., Sun, Y., Sun, L., Dai, H., Bi, H., Feng, K., Ma, K., et al. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-07288-z · Cited by 6
Zhang, Y., Chen, G., Xu, J. Y., Pang, L., Li, W., & Cheng, H. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-08143-1 · Cited by 5
Self-citationYuan, C., Wu, S., Wu, Y., Tian, C., Wang, Z., & Zhang, X. (2024) · Integrative Cancer Therapies · doi:10.1177/15347354241229414 · Cited by 5
Self-citationZhang, H., Kim, H., Yuan, T., Zhang, Z., Kaul, S. C., & Wadhwa, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020493 · Cited by 6
Li, S., Yu, C., Cheng, Y., Du, F., & Wen, G. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.11832 · Cited by 5
Qadir, J., Majid, S., Khan, M. S., Wani, M. D., & Naykoo, N. A. (2022) · Journal of Cancer Research and Therapeutics · doi:10.4103/jcrt.jcrt_1479_21 · Cited by 5
Cancer Neuroscience: Innovative Conception and Emerging Strategy of Therapy
Wang, T., Dong, Z., Wang, Y., An, Z., Wang, S., & Jin, W. (2026) · MedComm · doi:10.1002/mco2.70708 · Cited by 5
Zhang, T., Wang, Z., Zhang, B., & Tang, X. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108315 · Cited by 4
Tiwari, R. K., Rawat, S. G., Rai, S., & Kumar, A. (2025) · Endocrine · doi:10.1007/s12020-025-04161-7 · Cited by 6
Li, Z., Huang, Z., Wang, Z., Guo, Z., Wang, B., Li, Y., & Xu, E. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1644315 · Cited by 4
Cui, Y., Zhuang, M., Huang, Z., Guo, Y., Chen, F.-Z., Li, Y., Long, Y., Liu, Y., Zeng, G., Feng, X., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167031 · Cited by 4
Ryu, K.-J., Kim, S., Joung, C., Lee, S., Park, H., Song, J. Y., Pahk, K. J., & Pahk, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-79987-8 · Cited by 3
Zhang, L., Gao, S., Xiong, X., Liu, X., Li, R., Wang, X., Han, L., Xiao, X., Wang, X., Li, W., et al. (2025) · Advanced Science · doi:10.1002/advs.202504817 · Cited by 4
Self-citationAdvances in the study of the relationship between neurotransmitters and gastric cancer
Liu, Y.-Z., Liu, W.-X., & Deng, W.-H. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i44.113793 · Cited by 5
Li, R., Chen, J., Chen, Y., Jin, K., Chen, Y., Deng, C., Liu, X., & Li, Y. (2025) · Journal of International Medical Research · doi:10.1177/03000605251397839 · Cited by 4
Yi, H., Dai, Y., Chen, C., Ma, W., Zhang, Y., Wang, S., Jing, O., Liu, D., Wan, J., Wang, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.116062 · Cited by 3
Self-citationWang, X., Mei, W., Wang, Z., Ma, M., Wang, J., Ji, J., & Xing, X. (2026) · The Innovation · doi:10.1016/j.xinn.2026.101300 · Cited by 4
Kim, H. J., Ha, S., Joung, C., Kim, S., & Pahk, K. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1747732 · Cited by 3
LIU, H. J., Li, X., Yu, J., & Chen, T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1789297 · Cited by 3
Li, G., Qian, Y., Chen, Y., Cao, M., Yang, X., Kong, D., Wang, G., An, H., Yang, N., Huang, W., et al. (2022) · Oncology Letters · doi:10.3892/ol.2022.13617 · Cited by 4
Beta-blocker adjunct therapy as a prospective anti-metastatic with cardio-oncologic regulation
Nair, S. G., Benny, S., Jose, W. M., & Aneesh, T. P. (2024) · Clinical and Experimental Metastasis · doi:10.1007/s10585-023-10258-y · Cited by 4
Xu, M., Han, S., Yang, M., Chen, J., Liu, Y., Zhou, Y., & Shi, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-06017-6 · Cited by 3
Dubois, A., Renard, C., & Moreau, L. (2025) · Pharmaceutical Sciences and Drug Design · doi:10.51847/btqiq8isip · Cited by 3
Zhang, J.-H., Wang, K.-Y., Kubo, K., & Azuma, K. (2022) · Cancers · doi:10.3390/cancers14235950 · Cited by 1
Liu, L., Li, J., Lai, J., & Shi, S. (2023) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v15.i4.520 · Cited by 3
Bibliometric and visual analysis of chronic stress in cancer research from 2014 to 2024
Wei, Z., Li, A., Su, L., Zhang, B., & Yan, Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-01744-8 · Cited by 5
Xu, S., Wang, X., Wang, Y., Liu, M., & Chen, H. (2025) · Discover Oncology · doi:10.1007/s12672-025-02460-z · Cited by 3
Ghali, G. Z., & Ghali, M. G. Z. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05427-1 · Cited by 3
RetractedTranscription Factor E2F1 Regulates the Expression of ADRB2
Du, J., Rui, F., Hao, Z., Hang, Y., & Shu, J. (2023) · International Journal of Analytical Chemistry · doi:10.1155/2023/8210685 · Cited by 2
Niapour, A., Hosseinzadeh, S., Mohebi, Y., Momeni, H. S., & Tabibzadeh, S. (2025) · Medical Oncology · doi:10.1007/s12032-025-02966-0 · Cited by 2
The Discovery of α-Adrenoceptor Antagonists as a Potential New Treatment Option for Uveal Melanoma
He, Y., Liu, H., Hendgen-Cotta, U. B., Rassaf, T., Bechrakis, N. E., & Berchner‐Pfannschmidt, U. (2025) · Biomolecules · doi:10.3390/biom15101436 · Cited by 2
Zhao, R., Lu, Y., Xu, Q., Ren, H., Li, H., Gao, J., Cui, H., Yuan, Z., Cao, B., & Wei, B. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000004080 · Cited by 2
Prognostic significance of beta‐adrenergic receptor expression in oesophageal adenocarcinoma
Oliveira, T., Sasi, S., Trainor, J., McManus, D., McQuaid, S., Lewis, C. E., James, J. A., Coleman, H. G., McMenamin, Ú. C., & Turkington, R. C. (2026) · The Journal of Pathology Clinical Research · doi:10.1002/2056-4538.70070 · Cited by 2
Perioperative Immunomodulation and Cancer Recurrence
Villa, J. F., Ramirez, M. F., Anderson, J. L., Sikora, A. G., Sharma, J., & Cata, J. P. (2026) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000509 · Cited by 2
Sun, J., Zhang, C., Zhong, J., & Zhou, B. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218460 · Cited by 2
Momeni, H. S., Tabibzadeh, S., & Niapour, A. (2026) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70793 · Cited by 2
Cancer innervation: from mechanisms to clinical implications
Dai, X., Wang, X., & Wang, S. (2026) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2026.06.004 · Cited by 2
β-Adrenoceptors in Cancer: Old Players and New Perspectives
Amato, R., Lucchesi, M., Marracci, S., Filippi, L., & Monte, M. D. (2023) · Handbook of experimental pharmacology · doi:10.1007/164_2023_701 · Cited by 2
Liu, J., Zhu, Q., Jiang, H., Zhang, L., & Cao, X. (2023) · Cellular and Molecular Biology · doi:10.14715/cmb/2023.69.13.9 · Cited by 2
Self-citationNurkolis, F., Amalia, N., Tandi, Y. Y. P., Athallah, A. F., Aditya, M. R., Nojaid, A., Humardani, F. M., Prapriatna, A. F., Taslim, N. A., Harbuwono, D. S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26093987 · Cited by 2
Role of heredity, endogenous and exogenous factors in gastric cancer
Ershov, P. (2020) · Medicine of Extreme Situations · doi:10.47183/mes.2020.023 · Cited by 2
Drug Repurposing in Gastric Cancer: Current Status and Future Perspectives
Leite, M., Seruca, R., & Gonçalves, J. (2023) · Springer eBooks · doi:10.1007/978-3-031-21317-5_20 · Cited by 1
Tian, L., Li, T., Xu, L., & Huang, L. (2024) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.12044 · Cited by 1
Peripheral nerves-cancer cross-talk: the next frontier in cancer treatment
Wang, L., Qi, T., Tang, L., Wang, Y., ChenLiu, Z., Wang, D., & Tang, D. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05256-5 · Cited by 2
Mental distress and inflammation in bladder cancer: The nerve makes things less vague
Mikolášková, I., Gidron, Y., Ďurmanová, V., Suchánková, M., Bucová, M., & Hunáková, Ľ. (2025) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2025.100995 · Cited by 2
Liu, Y., Tian, S., Tan, Y., Yan, P., Liu, P., Zhu, H., Nomura, S., Huang, T., & Wei, Y. (2025) · Cancers · doi:10.3390/cancers17172789 · Cited by 1
Lü, Y., Li, Y., Can, Z., Guo, M., Liu, X., & Chen, X. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47100798 · Cited by 1
Qiu, L., Yao, S., Yang, Z., Zhou, Z., Yang, F., Zhu, X., Liu, F., Gong, Y., Li, S., Liu, M., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-15202-9 · Cited by 1
Jiang, W., Li, L., Huang, Q., Zhu, G., Zhang, Z., Zhang, Y., & Gao, X. (2025) · Medicine · doi:10.1097/md.0000000000046392 · Cited by 1
Self-citationLi, R., Chen, J., Chen, Y., Jin, K., Chen, Y., Deng, C., Liu, X., & Li, Y. (2026) · Clinical Medicine Insights Oncology · doi:10.1177/11795549251411762 · Cited by 3
Safaei, Y. M., Mahdavian, R., Soleymani, H., Rahimpour, N., Allahverdi, A., & Naderi-Manesh, H. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339764 · Cited by 1
Courtes, A. C., Myers, B., Daly, N., Jones, G., Soares, J. C., Zarate, C. A., & Machado‐Vieira, R. (2026) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2026.02.011 · Cited by 1
Luo, S., Qiao, S., Liu, L., Xiong, Z., Guo, L., Hao, X., Zhang, X., & Zhang, Y. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117340 · Cited by 1
Self-citationLiu, J., Qin, J., Zheng, W., Wang, X., Wei, Z., Xie, Z., Yan, T., Li, X. W., Ding, Z., Liu, H., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-72847-1 · Cited by 2
Traditional Chinese medicine mediated tumor suppression via regulating psychological factors
Shi, Y., Gu, L., Zhang, X., & Chen, M. (2022) · Medicine in Novel Technology and Devices · doi:10.1016/j.medntd.2022.100162 · Cited by 1
Self-citationGalán-González, E. F., & Gascón-Catalán, A. (2021) · Hacia la Promoción de la Salud · doi:10.17151/hpsal.2021.26.2.11 · Cited by 1
Metadata
- Authors
- Zhang, X., Zhang, Y., He, Z., Yin, K., Li, B., Zhang, L., & Xu, Z.
- Affiliations
- Affiliated Hospital of Xuzhou Medical College (CN)
- Nanjing University of Chinese Medicine (CN)
- Jiangsu Province Hospital (CN)
- Affiliated Hospital of Jiangsu University (CN)
- Corresponding author
- Xu, Zekuan
- Venue
- Cell Death & Disease
- Published
- 2019-10-17
- Volume
- 10
- Issue
- 11
- Pages
- 788-788
- ISSN
- 2041-4889 (ISSN-L)
- PMC
- PMC6797812
- OpenAlex
- W2981115917
- Cited by
- 261
- References
- 46
- Citations by year
- 2026: 43 · 2025: 48 · 2024: 32 · 2023: 34 · 2022: 55 · 2021: 32 · 2020: 16
- FWCI
- 20.51
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Cell Death and Disease (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (JX10231801, 81272712, 81572362, 20181119, BRA2015474, 81602080, 81272712, 81572362)
- Government of Jiangsu Province (333 Project)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, JX10231801, JX 10231801, 81572362, BRA2015474)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Stress, Anesthesia, and Immune Response
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Keywords
- chronic stress, gastric cancer, ADRB2, beta2-adrenergic receptor, adrenergic signaling, tumor progression, metastasis, chronic restraint stress, catecholamines, cortisol, propranolol, atenolol, NF-κB, STAT3, vascular endothelial growth factor, matrix metalloproteinases, cell proliferation, cell invasion
- MeSH terms
- Animals, Cell Movement, Female, Humans, Male, Mice, Inbred BALB C, Mice, Nude, Neoplasm Metastasis, RNA, Messenger, Stomach Neoplasms, Stress, Physiological, Signal Transduction, NF-kappa B, Receptors, Adrenergic, beta-2, Disease Progression, MAP Kinase Signaling System, Cell Proliferation, STAT3 Transcription Factor, Mice, Heterografts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review